Literature DB >> 31621532

M1 macrophage is the predominant phenotype in coronary artery lesions following Kawasaki disease.

Ryuji Ohashi1, Ryuji Fukazawa2, Akira Shimizu3, Shunichi Ogawa2, Masami Ochi4, Takashi Nitta4, Yasuhiko Itoh2.   

Abstract

Kawasaki disease (KD) is a systemic inflammatory process that affects the medium-sized arteries, causing various cardiovascular complications. However, it is not clear if the vascular sequelae following KD can predispose to the development of atherosclerosis later in life. Our aim was to examine the macrophage phenotypes in the coronary arteries forming giant aneurysms after KD to gain insight into the pathogenesis of vascular lesions in KD. We examined histological sections of the coronary arteries from five patients with KD who underwent coronary bypass grafting procedure as treatment for giant aneurysms and subsequent stenosis. Immunohistochemical expression of M1- and M2-macrophage markers was assessed to determine the macrophage phenotype of KD to compare with that of atherosclerosis in eight adult patients. All the KD specimens showed a mild to moderate degree of intimal thickening consisting of mature fibrous tissue and distortion of elastic fibers, mimicking the histological features of atherosclerosis. The total number of CD68 positive macrophages was higher in atherosclerosis than in KD specimens. Among the CD68 positive macrophages, the proportion of M1 phenotype, detected by CD86 or SOCS3, was higher in KD than in atherosclerosis. In contrast, the proportion of M2 phenotype, detected by CD163 or MRC1, was higher in patients with atherosclerosis. Despite similar histological features, KD and atherosclerosis appear to have a different immunological etiology for progression of the chronic vascular lesions. A further study enrolling a larger number of cases is required to delineate underlying mechanisms of vascular complications in KD.

Entities:  

Keywords:  Kawasaki disease; atherosclerosis; children; coronary artery disease; macrophage

Year:  2019        PMID: 31621532     DOI: 10.1177/1358863X19878495

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  4 in total

1.  Prediction of Immune Infiltration Diagnostic Gene Biomarkers in Kawasaki Disease.

Authors:  Hongjun Ba; Yao Wang; Lili Zhang; Huishen Wang; Zhan-Peng Huang; Youzhen Qin
Journal:  J Immunol Res       Date:  2022-06-17       Impact factor: 4.493

2.  KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease.

Authors:  Fenglei Zheng; Yijing Tao; Jingjing Liu; Zhimin Geng; Ying Wang; Yujia Wang; Songling Fu; Wei Wang; Chunhong Xie; Yiying Zhang; Fangqi Gong
Journal:  J Inflamm Res       Date:  2021-03-05

3.  Kawasaki Disease-like Vasculitis Facilitates Atherosclerosis, and Statin Shows a Significant Antiatherosclerosis and Anti-Inflammatory Effect in a Kawasaki Disease Model Mouse.

Authors:  Yusuke Motoji; Ryuji Fukazawa; Ryosuke Matsui; Noriko Nagi-Miura; Yasuo Miyagi; Yasuhiko Itoh; Yosuke Ishii
Journal:  Biomedicines       Date:  2022-07-26

Review 4.  Kawasaki syndrome: role of superantigens revisited.

Authors:  Donald Y M Leung; Patrick M Schlievert
Journal:  FEBS J       Date:  2020-08-24       Impact factor: 5.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.